C–X–C motif chemokine ligand 12: a potential therapeutic target in Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) is an X-linked recessive disease caused by a mutant dystrophin protein. DMD patients undergo gradual progressive paralysis until death. Chronic glucocorticoid therapy remains one of the main treatments for DMD, despite the significant side effects. However, its mech...
Main Authors: | Jie Chen, Xinsheng Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Bioengineered |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21655979.2021.1967029 |
Similar Items
-
Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al. -
Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
by: Michael Ogundele, et al.
Published: (2021-08-01) -
A rare case of dystrophinopathy: Duchenne muscular dystrophy–Becker muscular dystrophy intermediate complex
by: Rachna Gulati, et al.
Published: (2022-01-01) -
Rehabilitation therapy of Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2012-06-01) -
Absence of the dystrophin protein in Duchenne muscular dystrophy: effects on transcriptome, proteome and microRNA secretome
by: van Westering, T
Published: (2018)